General and Molecular PharMacoloGy General and Molecular PharMacoloGy Principles of drug action Edited By Francesco cleMenti and Guido FuMaGalli Co‐editors christiano chiaMulera, eMilio cleMenti, riccardo Fesce, dieGo Fornasari, and cecilia Gotti Translated and modified by Francesco Clementi and Guido Fumagalli. Originally published in Italian under the title “Farmacologia Generale e Molecolare. Il meccanismo d’azione dei farmaci”, 4th edition, by Francesco Clementi and Guido Fumagalli, © UTET SpA – Unione Tipografico-Editrice Torinese, Torino, Italy (2012). Copyright © 2015 by John Wiley & Sons, Inc. All rights reserved Published by John Wiley & Sons, Inc., Hoboken, New Jersey Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permissions. Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages. For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002. Wiley also publishes its books in a variety of electronic formats and by print-on-demand. Not all content that is available in standard print versions of this book may appear or be packaged in all book formats. If you have purchased a version of this book that did not include media that is referenced by or accompanies a standard print version, you may request this media by visiting http://booksupport.wiley.com. For more information about Wiley products, visit us at www.wiley.com. Library of Congress Cataloging-in-Publication Data General and molecular pharmacology : principles of drug action / Francesco Clementi, Guido Fumagalli, editors ; Christiano Chiamulera, Emilio Clementi, Riccardo Fesce, Diego Fornasari, Cecilia Gotti, co-editors. 1 online resource. Includes bibliographical references and index. Description based on print version record and CIP data provided by publisher; resource not viewed. ISBN 978-1-118-76859-4 (pdf) – ISBN 978-1-118-76868-6 (epub) – ISBN 978-1-118-76857-0 (cloth : alk. paper) I. Clementi, Francesco, editor. II. Fumagalli, Guido, editor. [DNLM: 1. Chemistry, Pharmaceutical. 2. Molecular Biology. 3. Pharmacological Phenomena. QV 744] RS403 615.1′9–dc23 2015008591 Printed in the United States of America 10 9 8 7 6 5 4 3 2 1 1 2015 CONTeNTS LIST OF CONTRIBUTORS xlvi PReFaCe xlix SeCTION 1 INTRODUCTION TO PHaRMaCOLOGY 1 1 essential Lexicon of Pharmacology 3 Francesco Clementi and Guido Fumagalli The Social Impact of Pharmacology, 3 Essential Lexicon, 4 Active Substances, 4 Pharmacological Disciplines, 5 Drug–Receptor Interactions, 6 Measure of the Clinical Response, 7 Take‐Home Message, 7 2 a Short History of Pharmacology 8 Vittorio A. Sironi Birth and Historical Developments of Pharmacology, 8 From Magical and Natural Remedies of Ancient Medicine to Arabic Alchemy, 8 From Monastic Medicine to Botanical Gardens, 9 From Anatomical Renaissance to the “Experienz”: Paracelsus’ Spagyric, 10 From Iatrochemistry to the Age of Enlightenment, 11 From the Search of the Active Principle to the Discovery of Alkaloids and Glucosides, 12 The Drug Synthesis Revolution: From Handmade to Industrial Production, 12 Modern Pharmacology, 13 Ehrlich and Chemotherapy: The Concept of Receptor, 13 The Birth of Modern Pharmacology, 14 The Biotechnology Era and the Pharmacology in the Third Millennium, 15 The Impact of New Biotechnologies: Molecular Biology, Bioinformatics, and Combinatorial Chemistry, 15 Biological Drugs and Pharmacology Perspectives, 16 vi CoNTENTS Personalized Therapies and New Sceneries in Pharmaceutical Industry, 17 Take‐Home Message, 18 Further Reading, 18 SeCTION 2 GeTTING THe DRUG TO ITS SITe OF aCTION 19 3 Cellular Basis of Pharmacokinetics 21 Riccardo Fesce and Guido Fumagalli A Quick Journey with the Drug in the Body, 21 Absorption, 21 Distribution, 21 Drug Elimination, 22 Crossing Cell Membranes, 23 Passive Diffusion across Cell Membranes, 24 Drug Transport across Cell Membranes, 25 Endocytosis, 25 Drug Diffusion to organs and Tissues, 27 Properties of the Most Important Cell Barriers, 27 Take‐Home Message, 30 Further Reading, 30 4 Drug absorption and administration Routes 31 Riccardo Fesce and Guido Fumagalli General Rules About Drug Absorption Rate, 32 Partition Coefficient, 32 Drug Dispersion, 32 Extension of the Absorbing Surface, 32 Permeability of the Absorbing Surface, 32 Vascularization, 33 Enteral Routes of Administration, 33 oral Route, 33 Sublingual and Rectal Routes, 35 Systemic Parenteral Routes of Administration, 35 The Intravascular Route, 35 i.m. Injection, 36 Subcutaneous and Intradermal Injections, 36 other Routes of Drug Administration, 36 Inhalation Route, 36 Topical/Regional Routes, 37 Intracavity Routes, 37 Dermal or Transcutaneous Route, 37 Mucosal Routes, 38 Absorption Kinetics, 38 General Rules, 38 Interrelation between Gene Therapy and Drug Delivery Techniques, 43 Take‐Home Message, 44 Further Reading, 44 5 Drug Distribution and elimination 45 Riccardo Fesce and Guido Fumagalli Distribution, 46 Tissues and Avidity for Drugs, 46 The Apparent Distribution Volume, 48 CoNTENTS vii Drug Binding to Plasma Proteins, 50 Factors That Determine the Distribution Rate of Drugs to the Various Compartments, 51 Elimination, 53 The Concept of Half‐Life, 53 The Concept of Clearance, 54 Renal Excretion of Drugs, 55 Glomerular Filtration, 56 Tubular Functions and Pharmacokinetics, 56 Active Transport of organic Anions and Cations, 56 Factors Determining Renal Clearance of Drugs, 57 Hepatic Excretion and Enterohepatic Cycle, 58 Perfusion, Binding to Plasma Proteins, Enzymatic Activity, and Hepatic Clearance, 59 Take‐Home Message, 59 Further Reading, 60 6 Drug Metabolism 61 Enzo Chiesara, Laura Marabini, and Sonia Radice Metabolic Modification of Drug Activity, 61 Two Phases of Drug Metabolism, 62 Phase I Reactions, 62 Phase II Enzymatic Reactions, 66 Extrahepatic Biotransformations, 68 Biotransformation by the Intestinal Flora, 69 Pharmacometabolic Induction and Inhibition, 69 Induction of Drug Metabolism, 69 Inhibition of Drug Metabolism, 71 Take‐Home Message, 72 Further Reading, 72 7 Control of Drug Plasma Concentration 73 Riccardo Fesce and Guido Fumagalli Time Course of Drug Plasma Concentration Following a Single Administration, 73 Drugs Distribute to organs and Tissues and then are Eliminated, 74 Description of Drug Plasma Concentration Time Course Following a Single Administration, 74 Area under the Plasma Concentration Curve (AUC), 74 The Plasma Concentration Peak, 75 Drug Plasma Concentration Time Course During Repetitive Administrations, 75 During Repetitive Administrations, the Drug Plasma Concentration Time Course Is Given by the Sum of the Time Courses of the Single Doses, 75 In a Chronic Therapy at Steady State, Each New Dose Replaces the Drug Amount that has been Eliminated Since the Last Administration, 77 The Time to Reach the Steady State Depends on the Drug Half‐Life, 77 Plasma Concentration at Steady State, 78 The Single Dose to Administer is Computed as a Function of the Interval between Successive Administrations, 78 Fluctuations of Drug Plasma Concentration at Steady State, 79 Absorption Kinetics Influence the Amplitude of oscillations in Plasma Concentration at Steady State, 80 Loading (Attack) Doses to Rapidly Attain Steady‐State Concentration, 80 Multicompartmental Kinetics, 81 Drug Binding to Plasma Proteins and Tissue Equilibration with Plasma, 81 viii CoNTENTS The Particular Case of the Nephron, 82 Drugs Redistribution among Compartments, 83 Corrections of the Therapeutic Regimen, 83 Normally Available Pharmacokinetic Data Are Average Values, 84 Varying Dosage as a Function of Body Weight and Physical Constitution, 84 Varying Dosage as a Function of Age, 84 Dosage Correction in the Presence of Hepatic Pathologies, 86 Dosage Correction in the Presence of Renal Pathologies, 86 Take‐Home Message, 87 Further Reading, 89 SeCTION 3 ReCePTORS aND SIGNaL TRaNSDUCTION 91 8 Drug–Receptor Interactions: Quantitative and Qualitative aspects 93 Gian Enrico Rovati and Valérie Capra General Properties of Drug Receptors, 93 Drug Receptors Are Molecules Relevant for Cellular Functions, 93 Not All Drugs Interact with a Receptor, 94 Drug Activity Follows to Drug–Receptor Complex Formation, 94 Drug–Receptor Interaction Is Mostly Mediated by Weak Chemical Bonds, 94 Reversible or Irreversible Drug–Receptor Interactions, 95 Characteristics of Drug–Receptor Interaction, 95 The Relationship between Drug Concentration and Drug–Receptor Complex Is Similar to the Michaelis–Menten Equation, 97 The Binding Isotherm and Its Linear Transformations Allow to obtain the Parameters of the Drug–Receptor Interaction, 97 Receptors Can Be Heterogeneous, 99 Drug Competition for a Same Receptor Binding Site, 99 Quantitative Aspects of Drug Effects: Dose–Response Curves, 99 Potency and Efficacy, 100 From Drug–Receptor Interaction to Drug Response, 101 occupancy Theory, 101 Modifications to the occupancy Assumption, 102 Efficacy Theory, 104 Nonlinear Function between Receptor occupancy and Tissue Response: EC Different from K, 106 50 d Constitutively Active Receptors and Inverse Agonists, 107 Two‐State Receptor Model and Beyond: Multiple Receptor States and “Biased” Signaling, 108 Take‐Home Message, 108 Further Reading, 108 9 Receptors and Modulation of Their Response 109 Francesco Clementi and Guido Fumagalli Classes of Receptors and Strategies of Signal Transduction, 109 Intracellular/Intranuclear Receptors, 110 Membrane Receptors, 110 Control of Receptor Localization in the Cell Membrane, 116 Intracellular Traffic of Cell Receptors, 117 How Receptors Reach the Cell Membrane and how Their Number is Regulated, 117 Modulation of Receptor Responses, 117 Receptor Modulation By Drugs, 118
Description: